Science and engineering research space at the nation's research-performing colleges and universities increased 3.5% from fiscal year (FY) 2009 to FY 2011, growing to 202.9 million net assignable square feet (NASF), according to recent data from the National Science Foundation's Survey of Science and Engineering Research Facilities. Biomedical fields account for the majority of the growth.
In a new business, sometimes the better part of wisdom is knowing when to quit, a new...
Among the procedures Army surgeon Hawkeye Pierce performed on "M.A.S.H." was an end-to...
In effort to show students the opportunities available in science-based career paths, Jennifer...
Shares of XenoPort Inc. sank Monday after the drug developer said a potential treatment for multiple sclerosis patients failed in late-stage clinical testing, and it will stop developing the drug. The Santa Clara, Calif., company said the treatment, labeled arbaclofen placarbil, failed to show a statistically significant improvement for patients taking it compared to a fake drug.
Aerospace conglomerate United Technologies Corp. says it's donated $3 million to establish an endowed professorship at the Yale Cancer Center in New Haven. Lieping Chen will be the first United Technologies Corp. Professor in Cancer Research and is known for research leading to clinical trials of new cancer drugs that harness the body's immune system to fight cancer.
Thomson Reuters announced a range of strategic enhancements to its Accelus BoardLink service, a secure board workflow solution designed to serve companies as they operate across borders and involve increasingly mobile, global boards. The boards of public companies face heightened scrutiny from investors, regulators, and the media, and are therefore increasingly reliant on technology for support and assistance.
Dow Chemical Co. said Tuesday it received a $2.2 billion payment from Petrochemical Industries Company of Kuwait, settling a dispute over a scrapped joint venture. A year ago, an international arbitration court awarded Dow $2.2 billion in damages stemming from Kuwait's move to withdraw from the joint venture.
Medtronic has put two new implantable heart devices on the market after receiving approval from federal regulators. The FDrA approved the sale of the Viva heart resynchronization devices and Evera implantable cardioverter defibrillators. Cardiac resynchronization therapy devices are used to treat heart failure and implantable defibrillators are used to treat rapid heartbeats.
BMC Software says it has agreed to be sold to a private investor group for about $6.6 billion in cash. BMC Software Inc. makes system management software for businesses. The Houston-based company says that the deal is for $46.25 per share. That's less than 2% above Friday's closing stock price of $45.42.
Bristol-Myers Squibb Co. said Friday that U.S. regulators expanded approval of its HIV drug Sustiva to children as young as three months old. The capsule-based drug was first approved in 1998 to treat HIV-infected children who are age three and older and weigh at least 22 pounds. The new approval expands the drug's use to children age three months to three years who weigh at least 7.7 pounds.
Intel's chief operating officer, Brian Krzanich, will become its next CEO in two weeks, tasked with steering the world's largest chipmaker through an industry shake-up that is seeing tablets and smartphones overshadow Intel's base in personal computers.
Japan's transport minister says the government is poised to allow Japanese carriers to resume flying the Boeing 787 once they complete repairs to problematic lithium ion batteries. Transport Minister Akihiro Ohta says in a statement on the ministry's Website that the approval could come as early as Friday night following an expected official safety order from U.S. federal regulators.
Honeywell International Inc. is buying privately held gas and radiation detection system maker RAE Systems Inc. for $340 million. Minneapolis-based Honeywell, which makes products ranging from aircraft systems to automotive parts and chemicals, said the acquisition will complement its existing business and expand its expertise and its geographic footprint, particularly in high-growth countries like China.
As airlines prepare to begin flying Boeing's beleaguered 787 Dreamliners again, federal investigators are looking at how regulators and the company tested and approved the plane's cutting-edge battery system, and whether the government cedes too much authority to aircraft makers for safety testing.
Companies around the world are still reluctant to go on the acquisition trail even though they are becoming are more confident about the global economy, a survey found Monday. In its half-yearly assessment of the intentions of big companies, accounting and consultancy firm Ernst & Young said the growing optimism has yet to be translated into more investment or corporate deal-making.
A company contracted by NASA to deliver supplies to the International Space Station successfully launched a rocket on Sunday in a test of its ability to send a cargo ship aloft. About 10 minutes after the launch from Wallops Island on Virginia's Eastern Shore, Orbital Sciences Corp. of Dulles declared the test a success after observing a practice payload reach orbit and safely separate from the rocket.
Investors who stood by Boeing during its 787 crisis have been rewarded. Things looked bad three months ago. Boeing's flagship plane was grounded worldwide because no one could explain the smoldering batteries on two different planes. Deliveries of the 787 to customers had stopped. No one knew how much the whole mess would cost.
There appears to be one less bidder pursuing an acquisition of slumping personal computer maker Dell. The Wall Street Journal reports that the Blackstone Group has retreated from its plans to submit an offer to buy most of Dell Inc.'s outstanding stock for $14.25 per share.
Taiwanese companies have long viewed tech giant Samsung as a major threat and the battle has recently appeared to tilt in favor of the South Korean rival as Taiwan's smartphone, memory chip, and display panel makers suffered sagging exports.
Thermo Fisher Scientific Inc. and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year end 2012).
Monsanto and Dow AgroSciences LLC said Thursday they reached a new licensing agreement to collaborate on biotech-engineered corn that is resistant to herbicide and insects. Under the agreement, Monsanto will license Dow's new Enlist weed control technology, which allows corn to tolerate weed-killing chemicals.
First Solar Inc., in a major strategic shift, will begin making a type of solar panel it has long competed against in an effort to win new customers. First Solar announced Tuesday it would acquire TetraSun, which has developed a design for high-efficiency solar panels, from JX Nippon Oil & Gas Energy Corp.
The biggest thing in operating rooms these days is a million-dollar, multi-armed robot named da Vinci, used in nearly 400,000 surgeries in America last year—triple the number just four years earlier. But now the high-tech helper is under scrutiny over reports of problems, including several deaths that may be linked with it, and the high cost of using the robotic system.
Vertex Pharmaceuticals Inc. said Friday it will work with Bristol-Myers Squibb Co. to study a potential hepatitis C treatment regimen that includes Bristol-Myers Squibb's drug daclatasvir and Vertex's VX-135. Both drugs are taken orally. Vertex said it will start a clinical trial of the once-per-day regimen during the second quarter.
General Electric Co. plans to spend $110 million on a new global research center in the Oklahoma City area that will create 125 new engineering jobs, Gov. Mary Fallin and GE Chairman and CEO Jeff Immelt said Wednesday. The center represents GE's longstanding commitment to technological innovation and will work toward advancements in the oil and natural gas fields that will help bring products to market faster, Immelt said.
BIND Therapeutics said Wednesday that Pfizer Inc. has agreed to pay it $160 million per drug as part of a collaboration to develop targeted medicines using nanotechnology which use particles measured in billionths of a meter. BIND is developing an experimental group of targeted, programmable...
Apple is seeking a patent for an iPhone that has a display that wraps around the edges of the device, expanding the viewable area and eliminating all physical buttons. The patent application reveals that Apple has put some thought into a device that takes advantage of a new generation of displays, which don't have to be flat and rigid like today's liquid-crystal displays, or LCDs.
The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar—flushing it out in patients' urine. The agency cleared J&J's Invokana tablets for adults with Type 2 diabetes, which affects an estimated 26 million Americans. The once-a-day medication works by blocking the kidneys from reabsorbing sugar, which occurs at higher levels in patients with diabetes than in healthy patients.